FDA Webinar on the Food Traceability Final Rule

(2:59:15)

FDA Webinar on the Infant Formula Transition Plan (Part 4)

(1:10:23)

FDA Webinar on the Guidance for Industry on Infant Formula Enforcement Discretion Policy

(44:23)

FDA Stakeholder Webinar on Action Levels for Lead in Juice: Guidance for Industry

(1:40)

FDA Webinar on New Infant Formula Transition Plan (Part 2)

(57:22)

FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)

(53:23)

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Drugs Day 2

(7:46:19)

FDA Webinar on Allergen Labeling for Retail Food Stores and Food Service Establishments

(32:43)

Framework for FDA’s Real-World Evidence Program – Mar 15, 2019

(49:45)

Start Your Natural Wellness Journey with the WAVwatch 2.0 #acousticwavetherapy

(59:48)

October 31, 2024 Endocrinologic and Metabolic Drugs Advisory Committee

(9:5:10)

Understanding the New Returns and Exceptions Process

(54:5)

FDA Clinical Investigator Training Course (CITC) 2024 – Day Two – Session Two

(2:23:52)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

(4:38:30)

August 2, 2024 Meeting of the Genetic Metabolic Diseases Advisory Committee (GeMDAC)

(8:30:)

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Devices Day 2/Biologics Day 1

(8:29:5)

November 19, 2024 Joint Meeting of the DSaRM and the PDAC

(8:52:38)

Understanding FDA Inspections and Data

(1:56:15)

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Devices Day 1

(7:34:55)

FDA Webinar: Action Levels for Lead in Food Intended for Babies and Young Children: Draft Guidance

(1:26)

FDA Tobacco Compliance Webinars: Tobacco Product Listing Updates

(7:8)

FDA’s Rulemaking Process and Planned Tobacco Product Standards webinar

(50:53)

FDA Foodborne Outbreak Response Improvement Plan Webinar

(1:3:)

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Plenary + Drugs Day 1

(7:42:41)

FDA Webinar on the Infant Formula Transition Plan (Part 3)

(41:53)

FDA’s Discussion Paper: 3D Printing Medical Devices at the Point of Care

(55:27)

2021 FDA Science Forum: Main Session and Keynote

(56:38)

FSMA Webinar: Final Rule for Produce Safety

(58:47)

Compliance Training for Small Tobacco Manufacturers, Domestic Establishment Inspections

(19:2)

FDA Webinar on Guidance for Industry: Infant Formula Enforcement Discretion Policy - Q\u0026A Session

(30:4)